To compare the enhancement pattern of normal facial nerves on 3D-FLAIR and 3D-T1-FFE-F) sequences at 3.0 T MR units.
MR imaging of patients with facial neuritis is not usually indicated except in patients with facial palsy with atypical manifestations and those with intractable palsy despite therapy. In most patients, the diagnosis of facial neuritis is clinically evident and is confirmed by EPS. EPS can also provide prognostic information on outcomes in patients with acute facial paralysis. The major disadvantage of EPS is its inability to detect diagnostic abnormalities of the nerve distal to the stylomastoid foramen within 1 week of symptom onset.
Although the diagnostic utility of MRI in patients with facial neuritis has been studied over the past 20 years, its results have been largely disappointing (1) (2) (3) (4) (5) . 
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ing and evaluating prognosis in patients with facial neuritis. For example, the geniculate ganglion, tympanic or mastoid segment of the normal facial nerve may be significantly enhanced in up to 76% of patients due to the distribution of arteriovenous plexus along this facial nerve (6, 7) . This, in turn, may block evaluation of the relatively minor pathologic enhancement of the nerves resulting from breakdown of the blood nerve barrier on conventional MR images (6, 7) . Thus, compared with EPS, MRI plays a limited role in the diagnosis and evaluation of patients with facial neuritis (8) .
Recently, a new MR sequence, three -dimensional (3D) fluid attenuated inversion recovery (FLAIR), has been used to image temporal bone pathologies. In contrast to conventional MRI sequences, 3D-FLAIR sequences have been reported to be useful in diagnosing mumps deafness and sudden sensorineural hearing loss and in predicting the prognosis of patients with sudden sensorineural hearing loss (9) (10) (11) . FLAIR imaging is highly sensitive to subtle changes in longitudinal magnetization in the fluid space, which, in contrast to T1-weighed images, decrease as the concentration of contrast agent increases (12, 13) . 3D-FLAIR sequences can also suppress signal from the fluid at a velocity exceeding 1.0 cm/s (14) . We hypothesized that facial neuritis may be more accurately imaged on 3D-FLAIR images than on T1-FFE images without normal enhancement of the arteriovenous plexus along the facial nerve. We therefore, evaluated the pattern of enhancment of the normal facial nerve on 3D-FLAIR sequence at 3.0 T MRI, to provide baseline data for future studies re-evaluating the clinical utility of MRI for patients with facial neuritis.
Patients
We evaluated 20 consecutive subjects with no history of facial nerve abnormalies, who underwent temporal bone MRI with contrast enhancement between January 2008 and March 2009. The MRI images analyzed were those from the contralateral normal side in all subjects. In all patients, there was no symptoms related facial nerve abnormality according to medical records. Our study was approved by the institutional review board of our hospital, and informed consent was waived due to the retrospective of this study.
MR imaging
All MR scans were performed using a 3.0-T MR unit (Intera Achieva, Philips Medical Systems, Best, the Netherlands) and an 8-element phased array sensitivity-encoding (SENSE) head coil. MR images analyzed were pre-, and post-contrast-3D-FLAIR sequences and 3D-T1-FFE-FS sequences using Gd-DOTA (0.1 mmol/kg body weight; Dotarem; Guerbet, Paris, France). The mean time from contrast administration to post-contrast 3D-FLAIR imaging was 7 min.
The parameters for 3D-FLAIR were: TR, 8,000 ms; TE, 268 ms; TI, 2,400 ms; ET L, 80; modulation of flip angle for refocusing pulses; section thickness, 0.6 mm; over contiguous slices; 60 sections; FOV, 18 × 18 cm; matrix size, 512 × 512; NEX, 1; and acquisition time, 
MATERIALS AND METHODS

Image analysis
Each facial nerve was divided into five segments; canalicular, labyrinthine, genu, tympanic and mastoid segments. The pattern of enhancement was visually assessed by two neuro-radiologists, one with 5 years and one with 13 years of experience, who independently reviewed pre-/post-enhanced 3D-T1-FFE-FS sequences, and, 2 weeks later, evaluated pre-/postenhanced 3D-FLAIR sequences. The two image sets for each patient were randomly interpreted during different sessions. The degree of enhancement in each segment was estimated using a 3-point rating scale, with grade 0 indicating no enhancement; grade 1 indicating mild enhancement, but only when compared with the corresponding precontrast scan; and grade 2 indicating strong enhancement, when enhancement was obvious without comparison.
Statistical analysis
For both 3D-FLAIR and 3D-T1-FFE-FS sequences, we evaluated the degree of enhancement for each segment of the facial nerve. We also calculated interobserver agreement between two neuroradiolo- gists. All statistical analyses were performed using Medcalc for Windows (version 11.2.1; MedCalc Software; Mariakerke, Belgium).
There were 5 men and 15 women with a mean age of 50 years, ranging from 8 to 71. Twelve patients were diagnosed with unilateral sudden sensorineural hearing loss and 8 with acoustic neuroma.
On 3D-FLAIR sequences, only two subjects showed contrast enhancement, showing a mild (grade 1) degree of enhancement on the genu segment, as assessed by at least one of the reviewers. In contrast, 13 (65%) of 20 subjects showed enhancement of at least one segment on 3D-T1-FFE-FS images (Table 1) .
Of the 100 segments examined, 17 were positive on 3D-T1-FFE-FS images, as determined by at least 1 reviewer, with the mastoid segment being the most common site of enhancement (Fig. 1) . The two reviewers differed on the presence of enhancement in nine segments and on the degree in three segments. Distribution of the degree of enhancement in all 17 segments is shown in Fig. 2 . Although the interobserver agreement on the occurrence of enhancement of normal facial nerve segments on 3D-T1-FFE-FS images was good (κ= 0.589), the interobserver agreement on the degree of enhancement was only moderate (κ= 0.459). An example is shown in Fig. 3 .
On Gd-DTPA-enhanced T1-weighed MRI, the geniculate ganglion, the greater superficial petrosal nerve, and the proximal tympanic and mastoid segments of the normal facial nerve may be enhanced due to the flux of contrast material in the lush circumneural arteriovenous plexus. In contrast, the normal cisternal, intracanalicular and labyrinthine segments are not enhanced. Therefore, on Gd-DTPA-enhanced T1-weighted MRI, it may be difficult to determine whether enhancement of the facial nerve is indicative of disease (6, 15) .
Our results indicate that 3D-FLAIR sequences may have advantages over 3D-T1-FFE-FS sequences in evaluating the actual enhancement of the normal facial nerve. While 1 of 2 reviewers observed only mild enhancement of the genu segment in 2 patients on 3D-FLAIR sequences, at least 1 reviewer observed enhancement of at least one segment of the facial nerve on 3D-T1-FFE-FS sequences in 13 of 20 (65%) subjects. Segments enhanced included the genu, the tympanic and the mastoid, corresponding to previous results showing that at least one segment of the normal facial nerve is enhanced in 76% of patients on post-contrast 2D -or 3D -T1 -weighted sequences (6, (15) (16) (17) .
Our results supported by the characteristics of the 3D-FLAIR sequence. This sequence is not only more sensitive to lower gadolinium concentrations but is less sensitive to high gadolinium concentrations than T1-weighed sequences. Thus, regions with higher concentrations of gadolinium do not appear enhanced because the signal-reducing T2 effect will obscure the signal-enhancing T1 effect (18) . Furthermore, this sensitivity of 3D-FLAIR sequences to gadolinium contrast is abruptly reduced as flow velocity above is increased above 1.0 cm/sec (14) .
Due to these characteristics of 3D-FLAIR sequences despite there is no known report about the gadolinium concentration or flow velocity of the arteriovenous plexus of the human facial nerve, we can assume that the prominent contrast enhancement of the lush circumneural arteriovenous plexus surrounding the normal facial nerve, visible on post-contrast T1-weighted images, was no longer visible on 3D-FLAIR sequences. Therefore, in the absence of normal enhancement of the arteriovenous plexus along the facial nerve, facial neuritis may be more accurately imaged on 3D-FLAIR than on T1-FFE images. This, however, requires validation in future studies.
Our study had several limitations. First, the interpretation of MR images may have been biased because the reviewers knew prior to evaluation that these facial nerves were normal. This may have resulted in underestimation of the normal enhancement of the facial nerve on MR images. To minimize the interpretation bias, we strictly defined the grade of enhancement on MR images and evaluated interobserver agreement to determine the consistency of our interpretation of 3D-T1-FFE-FS images. However, interobserver agreement could not be estimated for 3D-FLAIR images because too few subjects showed positive results. Therefore, the results of our preliminary study should be validated by further evaluations, including both normal controls and patients with facial neuritis. Second limitation of our study was that the number of normal subjects was relatively small, and the age and sex were not corrected statistically. However, previous studies of the enhancement pattern of facial nerves on MRI had included similar numbers of subjects (6) . Moreover the number of subjects analyzed (20) seems to be sufficient for statistical analysis. Finally, twelve patients enrolled in this study had a history of sudden sensorineural hearing loss, of which etiologies might be viral or autoimmune process. However, the possibility of subclinical involvement of the facial nerve might be extremely low because we evaluated the facial nerves located in the contralateral asymptomatic side of the temporal bones.
Our results indicate that 3D-FLAIR sequences could substantially eliminate the normal enhancement of the arteriovenous plexus surrounding the normal facial nerve that has been observed with previous MR sequences such as post-contrast 2D-and 3D-T1-weighted images. The use of contrast-enhanced 3D-FLAIR sequences, we may increase the diagnostic specificity of MRI for facial neuritis. 
